Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications

Abstract The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective glucose metabolism, obesity, cardiovascular disease and an inability to mount an effective immune response to certain pathogenic organisms. Perturbations in key innate immune receptors known as To...

Full description

Bibliographic Details
Main Authors: Saket Gupta, Ashwini Maratha, Jakub Siednienko, Anandan Natarajan, Thusitha Gajanayake, Shu Hoashi, Sinéad Miggin
Format: Article
Language:English
Published: Nature Portfolio 2017-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-07230-8
_version_ 1818749224642150400
author Saket Gupta
Ashwini Maratha
Jakub Siednienko
Anandan Natarajan
Thusitha Gajanayake
Shu Hoashi
Sinéad Miggin
author_facet Saket Gupta
Ashwini Maratha
Jakub Siednienko
Anandan Natarajan
Thusitha Gajanayake
Shu Hoashi
Sinéad Miggin
author_sort Saket Gupta
collection DOAJ
description Abstract The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective glucose metabolism, obesity, cardiovascular disease and an inability to mount an effective immune response to certain pathogenic organisms. Perturbations in key innate immune receptors known as Toll-like receptors (TLRs) and inflammatory mediators such as IL-6, TNFα and IL-1β have been linked with T2DM. Herein, we sought to establish whether patients with T2DM and underlying complications exhibit perturbations in cytokine and TLR expression. Serum cytokine and mRNA levels of cytokines/TLRs in monocytes (M) and neutrophils (N) were measured in a cohort of 112 diabetic patients: good glycaemic control without complications (GC), good glycaemic control with complications (GCC), poor glycaemic control without complications (PC) and poor glycaemic control with complications (PCC) and compared them with 34 non-diabetic volunteers (NGT). Serum cytokine levels were normal in all study participants. In the GC group, cytokine and TLR gene expression were enhanced compared to NGT. In contrast, suppressed cytokine and TLR gene expression were evident in PC, GCC & PCC groups when compared to the GC. In conclusion, whereas serum pro-inflammatory cytokine levels are unaltered in T2DM patients, differences in inflammatory gene profiles exist among the T2DM patient groups.
first_indexed 2024-12-18T04:00:23Z
format Article
id doaj.art-5e5f494fbf684e968ca4a373c602bbd9
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-18T04:00:23Z
publishDate 2017-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5e5f494fbf684e968ca4a373c602bbd92022-12-21T21:21:42ZengNature PortfolioScientific Reports2045-23222017-08-017111010.1038/s41598-017-07230-8Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complicationsSaket Gupta0Ashwini Maratha1Jakub Siednienko2Anandan Natarajan3Thusitha Gajanayake4Shu Hoashi5Sinéad Miggin6Midlands Regional HospitalImmune Signalling laboratory, Institute of Immunology, Department of Biology, Maynooth UniversityImmune Signalling laboratory, Institute of Immunology, Department of Biology, Maynooth UniversityMidlands Regional HospitalImmune Signalling laboratory, Institute of Immunology, Department of Biology, Maynooth UniversityMidlands Regional HospitalImmune Signalling laboratory, Institute of Immunology, Department of Biology, Maynooth UniversityAbstract The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective glucose metabolism, obesity, cardiovascular disease and an inability to mount an effective immune response to certain pathogenic organisms. Perturbations in key innate immune receptors known as Toll-like receptors (TLRs) and inflammatory mediators such as IL-6, TNFα and IL-1β have been linked with T2DM. Herein, we sought to establish whether patients with T2DM and underlying complications exhibit perturbations in cytokine and TLR expression. Serum cytokine and mRNA levels of cytokines/TLRs in monocytes (M) and neutrophils (N) were measured in a cohort of 112 diabetic patients: good glycaemic control without complications (GC), good glycaemic control with complications (GCC), poor glycaemic control without complications (PC) and poor glycaemic control with complications (PCC) and compared them with 34 non-diabetic volunteers (NGT). Serum cytokine levels were normal in all study participants. In the GC group, cytokine and TLR gene expression were enhanced compared to NGT. In contrast, suppressed cytokine and TLR gene expression were evident in PC, GCC & PCC groups when compared to the GC. In conclusion, whereas serum pro-inflammatory cytokine levels are unaltered in T2DM patients, differences in inflammatory gene profiles exist among the T2DM patient groups.https://doi.org/10.1038/s41598-017-07230-8
spellingShingle Saket Gupta
Ashwini Maratha
Jakub Siednienko
Anandan Natarajan
Thusitha Gajanayake
Shu Hoashi
Sinéad Miggin
Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
Scientific Reports
title Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_full Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_fullStr Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_full_unstemmed Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_short Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_sort analysis of inflammatory cytokine and tlr expression levels in type 2 diabetes with complications
url https://doi.org/10.1038/s41598-017-07230-8
work_keys_str_mv AT saketgupta analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT ashwinimaratha analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT jakubsiednienko analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT anandannatarajan analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT thusithagajanayake analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT shuhoashi analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT sineadmiggin analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications